State Street’s Tevogen Bio Holdings TVGN Stock Holding History

State Street’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,655	Closed	-$44K	–	4351
2025 Q4	$44K	Buy	2,655 +353	+15%	+$9.18K	﹤0.01%	4176
2025 Q3	$90.4K	Sell	2,302 -574	-20%	-$28.2K	﹤0.01%	4065
2025 Q2	$180K	Buy	2,876 +649	+29%	+$37K	﹤0.01%	3860
2025 Q1	$120K	Buy	2,227 +514	+30%	+$33.8K	﹤0.01%	3932
2024 Q4	$88.2K	Buy	1,713 +384	+29%	+$25K	﹤0.01%	4016
2024 Q3	$24.5K	Buy	1,329 +38	+3%	+$1.11K	﹤0.01%	4201
2024 Q2	$46.7K	Buy	+1,291	New	+$84.1K	﹤0.01%	4152

Other funds holding TVGN

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street's TVGN Position: Q1 2026 in Review

State Street sold out of Tevogen Bio Holdings (TVGN) in Q1 2026, closing a stake of 2,655 shares — an estimated $44K sold.

State Street first reported a position in TVGN in Q2 2024 and held it in 7 quarters. The position peaked at $180K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

State Street reported no remaining Tevogen Bio Holdings position as of Q1 2026 after selling out during the quarter.
State Street sold 2,655 Tevogen Bio Holdings shares in Q1 2026, an estimated $44K.
State Street first reported a position in Tevogen Bio Holdings in Q2 2024 and held it in 7 quarters.
State Street's Tevogen Bio Holdings position peaked at $180K in Q2 2025.
30 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.